Key facts
- This page summarizes Susan K. Langer's Form 4 filing for BIOGEN INC. (BIIB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 11 Jun 2026, 17:34.
Susan K. Langer - 09 Jun 2026 Form 4 Insider Report for BIOGEN INC. (BIIB)
- Reporting relationship
- Director
- Issuer ticker
- BIIB
- Reported as of
- 09 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Jun 2026, 17:34:50 UTC
- Prior SEC filing
- 18 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Wendell Taylor, attorney-in-fact for Susan K. Langer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Susan K. Langer filed Form 4 for BIOGEN INC. (BIIB) on 11 Jun 2026.
Change
- Previous filing in this sequence was filed on 18 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001982640
Primary reporting owner
LANGER SUSAN
- Relationship
- Director
- Address
- 225 BINNEY, CAMBRIDGE
- Signature
- /s/ Wendell Taylor, attorney-in-fact for Susan K. Langer
- Signature date
- 11 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIIB
transaction
Common Stock
Award
- Transaction value
- Shares
- +1,505
- Change %
- +29%
- Price
- $0.000000*
- Shares after
- 6,634
- Date
- 09 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.